被指定吸尼古丁含量极低的香烟的精神病患者或社会经济弱势人群的体重变化。

IF 2.4 3区 医学 Q3 PHARMACOLOGY & PHARMACY Experimental and clinical psychopharmacology Pub Date : 2024-04-01 Epub Date: 2024-01-18 DOI:10.1037/pha0000700
Roxanne F Harfmann, Sarah H Heil, Janice Y Bunn, L Morgan Snell, Jennifer W Tidey, Stacey C Sigmon, Diann E Gaalema, Dustin C Lee, Joanna M Streck, Cecilia L Bergeria, Danielle R Davis, Shirley Plucinski, Stephen T Higgins
{"title":"被指定吸尼古丁含量极低的香烟的精神病患者或社会经济弱势人群的体重变化。","authors":"Roxanne F Harfmann, Sarah H Heil, Janice Y Bunn, L Morgan Snell, Jennifer W Tidey, Stacey C Sigmon, Diann E Gaalema, Dustin C Lee, Joanna M Streck, Cecilia L Bergeria, Danielle R Davis, Shirley Plucinski, Stephen T Higgins","doi":"10.1037/pha0000700","DOIUrl":null,"url":null,"abstract":"<p><p>Nicotine abstinence leads to weight gain, which could be an unintended consequence of a nicotine reduction policy. This secondary analysis used weekly assessments of weight and ratings of \"increased appetite/hunger/weight gain\" collected in three 12-week, randomized controlled trials evaluating the effects of cigarettes differing in nicotine dose (15.8, 2.4, or 0.4 mg/g) among individuals with affective disorders, opioid use disorder (OUD), and socioeconomically disadvantaged women. Linear mixed models tested differences by dose and time. Analyses first collapsed across populations and then separated out individuals with OUD because biomarkers suggested they used substantially more noncombusted nicotine. Across populations, weight increased significantly over time, averaging 1.03 kg (<i>p</i> < .001), but did not vary by dose nor was there any interaction of dose/time. \"Increased appetite/hunger/weight gain\" ratings increased significantly as a function of dose, with differences between low and high doses (1.95 and 1.73, respectively, <i>p</i> = .01), but not by time nor any interaction. In the combined group of individuals with affective disorders and socioeconomically disadvantaged women, weight and \"increased appetite/hunger/weight gain\" ratings increased significantly by dose, with differences between low and high doses (1.43 vs. 0.73 kg, <i>p</i> = .003 and 2.00 vs. 1.76, <i>p</i> = .02, respectively). Among individuals with OUD, there were no significant effects of any kind on either outcome. Individuals with affective disorders and socioeconomically disadvantaged women gained weight and reported more subjective appetite/weight gain when given 0.4, but not 2.4 mg/g cigarettes, despite comparable decreases in nicotine exposure. However, neither change was clinically significant, suggesting minimal short-term adverse consequences of a nicotine reduction policy. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>","PeriodicalId":12089,"journal":{"name":"Experimental and clinical psychopharmacology","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Changes in weight among individuals with psychiatric conditions or socioeconomic disadvantage assigned to smoke very low nicotine content cigarettes.\",\"authors\":\"Roxanne F Harfmann, Sarah H Heil, Janice Y Bunn, L Morgan Snell, Jennifer W Tidey, Stacey C Sigmon, Diann E Gaalema, Dustin C Lee, Joanna M Streck, Cecilia L Bergeria, Danielle R Davis, Shirley Plucinski, Stephen T Higgins\",\"doi\":\"10.1037/pha0000700\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Nicotine abstinence leads to weight gain, which could be an unintended consequence of a nicotine reduction policy. This secondary analysis used weekly assessments of weight and ratings of \\\"increased appetite/hunger/weight gain\\\" collected in three 12-week, randomized controlled trials evaluating the effects of cigarettes differing in nicotine dose (15.8, 2.4, or 0.4 mg/g) among individuals with affective disorders, opioid use disorder (OUD), and socioeconomically disadvantaged women. Linear mixed models tested differences by dose and time. Analyses first collapsed across populations and then separated out individuals with OUD because biomarkers suggested they used substantially more noncombusted nicotine. Across populations, weight increased significantly over time, averaging 1.03 kg (<i>p</i> < .001), but did not vary by dose nor was there any interaction of dose/time. \\\"Increased appetite/hunger/weight gain\\\" ratings increased significantly as a function of dose, with differences between low and high doses (1.95 and 1.73, respectively, <i>p</i> = .01), but not by time nor any interaction. In the combined group of individuals with affective disorders and socioeconomically disadvantaged women, weight and \\\"increased appetite/hunger/weight gain\\\" ratings increased significantly by dose, with differences between low and high doses (1.43 vs. 0.73 kg, <i>p</i> = .003 and 2.00 vs. 1.76, <i>p</i> = .02, respectively). Among individuals with OUD, there were no significant effects of any kind on either outcome. Individuals with affective disorders and socioeconomically disadvantaged women gained weight and reported more subjective appetite/weight gain when given 0.4, but not 2.4 mg/g cigarettes, despite comparable decreases in nicotine exposure. However, neither change was clinically significant, suggesting minimal short-term adverse consequences of a nicotine reduction policy. (PsycInfo Database Record (c) 2024 APA, all rights reserved).</p>\",\"PeriodicalId\":12089,\"journal\":{\"name\":\"Experimental and clinical psychopharmacology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Experimental and clinical psychopharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1037/pha0000700\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/18 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental and clinical psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1037/pha0000700","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/18 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

禁用尼古丁会导致体重增加,这可能是尼古丁减量政策的意外后果。这项二次分析使用了三项为期 12 周的随机对照试验中收集的每周体重评估和 "食欲增加/饥饿/体重增加 "评级,这些试验评估了尼古丁剂量(15.8、2.4 或 0.4 mg/g)不同的香烟对情感障碍患者、阿片类药物使用障碍患者和社会经济条件较差的女性的影响。线性混合模型测试了不同剂量和时间的差异。首先对不同人群进行分析,然后将患有阿片类药物滥用症的人分离出来,因为生物标志物表明他们使用了更多的非燃烧尼古丁。在不同人群中,体重随着时间的推移显著增加,平均增加了 1.03 千克(p < .001),但并不因剂量而异,也不存在剂量/时间的交互作用。"食欲增加/饥饿/体重增加 "的评分随着剂量的增加而显著增加,低剂量和高剂量之间存在差异(分别为 1.95 和 1.73,p = .01),但与时间和交互作用无关。在情感障碍患者和社会经济处境不利的妇女的联合组中,体重和 "食欲增加/饥饿/体重增加 "评级随剂量的增加而显著增加,低剂量和高剂量之间存在差异(分别为 1.43 千克和 0.73 千克,p = .003 和 2.00 千克和 1.76 千克,p = .02)。在 OUD 患者中,任何一种结果都没有显著影响。尽管尼古丁暴露量的下降幅度相当,但如果给患有情感障碍的人和社会经济条件较差的妇女吸食 0.4 毫克/克的香烟,她们的体重会增加,而且主观食欲/体重增加的幅度更大,而吸食 2.4 毫克/克的香烟则不会增加。不过,这两种变化都没有临床意义,表明减少尼古丁政策的短期不利影响极小。(PsycInfo Database Record (c) 2024 APA, 版权所有)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Changes in weight among individuals with psychiatric conditions or socioeconomic disadvantage assigned to smoke very low nicotine content cigarettes.

Nicotine abstinence leads to weight gain, which could be an unintended consequence of a nicotine reduction policy. This secondary analysis used weekly assessments of weight and ratings of "increased appetite/hunger/weight gain" collected in three 12-week, randomized controlled trials evaluating the effects of cigarettes differing in nicotine dose (15.8, 2.4, or 0.4 mg/g) among individuals with affective disorders, opioid use disorder (OUD), and socioeconomically disadvantaged women. Linear mixed models tested differences by dose and time. Analyses first collapsed across populations and then separated out individuals with OUD because biomarkers suggested they used substantially more noncombusted nicotine. Across populations, weight increased significantly over time, averaging 1.03 kg (p < .001), but did not vary by dose nor was there any interaction of dose/time. "Increased appetite/hunger/weight gain" ratings increased significantly as a function of dose, with differences between low and high doses (1.95 and 1.73, respectively, p = .01), but not by time nor any interaction. In the combined group of individuals with affective disorders and socioeconomically disadvantaged women, weight and "increased appetite/hunger/weight gain" ratings increased significantly by dose, with differences between low and high doses (1.43 vs. 0.73 kg, p = .003 and 2.00 vs. 1.76, p = .02, respectively). Among individuals with OUD, there were no significant effects of any kind on either outcome. Individuals with affective disorders and socioeconomically disadvantaged women gained weight and reported more subjective appetite/weight gain when given 0.4, but not 2.4 mg/g cigarettes, despite comparable decreases in nicotine exposure. However, neither change was clinically significant, suggesting minimal short-term adverse consequences of a nicotine reduction policy. (PsycInfo Database Record (c) 2024 APA, all rights reserved).

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.20
自引率
8.70%
发文量
164
审稿时长
6-12 weeks
期刊介绍: Experimental and Clinical Psychopharmacology publishes advances in translational and interdisciplinary research on psychopharmacology, broadly defined, and/or substance abuse.
期刊最新文献
Evaluating the human abuse potential of concurrent use of electronic cigarettes and low nicotine cigarettes among adults who smoke. Residual next-day effects of alprazolam on psychomotor performance and simulated driving in healthy normal adults. Efficacy and safety of balovaptan for posttraumatic stress disorder: A randomized, placebo-controlled trial. A behavioral choice analysis of the role of life events during early nonabstinent natural recovery from alcohol use disorder. An experimental investigation into the impact of acute stress on alcohol craving.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1